Skip to content
★ Sign in to follow
ML

Max Link

Alexion Pharmaceuticals IncImunon, Inc.Windtree Therapeutics IncCytrx CorpHuman Genome Sciences IncSintx Technologies, Inc.
Total declarations
68
Companies
6
▲ Purchases (16 ops.)
€648k
▼ Sales (11 ops.)
€22.5M

Latest filing published 14 Aug 2014 for Sintx Technologies, Inc..

Insider track record

Disclosed buys
16
Disclosed sells
11
Signal history

No signal scores available.

Closed purchases

Market purchases
16
Positive at T+90
60%
Median T+90
+63.6%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 27 Jul 2011 · 5583 days ago · €139k
    +22.0%
    Entry US$45,528.79 · Close at T+365 US$55,522.91
  • Filed 23 Dec 2009 · 6164 days ago · €21k
    -10.5%
    Entry US$35,411.28 · Close at T+365 US$31,709.75
  • Filed 21 Nov 2008 · 6561 days ago · €4,534
    +48.6%
    Entry US$27,144.54 · Close at T+365 US$40,346.65
  • Filed 27 Feb 2007 · 7194 days ago · €27k
    +38.2%
    Entry US$47,749.71 · Close at T+365 US$66,010.58
  • Filed 17 Mar 2006 · 7541 days ago · €33k
    +6.7%
    Entry US$51,327.85 · Close at T+365 US$54,782.61

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Max Link: trading record in brief

This profile gathers the share dealings of Max Link across 6 companies, led by Alexion Pharmaceuticals Inc, Imunon, Inc. and Cytrx Corp. Over a trading history stretching from 9 January 2006 to 12 August 2014, the count stands at 68 filings.

The open-market side counts 16 purchases for €648k alongside 11 sales for €22.5M. Sales outweigh purchases by €21.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 13 share grants and 25 option exercises. So far in 2014, the count stands at no purchases and 4 sales.

A typical purchase (the median) is worth €33k. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +63.6%. This is a record of the past, not a forecast.

The latest filing, published on 14 August 2014, reports a share grant in Sintx Technologies, Inc. The last purchase on record was published on 11 December 2012, which is 5,080 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Max Link

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations68 total
  • ◆
    DirectorExecutivesSintx Technologies, Inc.
    0SEC
    6,984 shares0Common StockSEC:0001209191-14-052500:0
  • ◆
    DirectorExecutivesAlexion Pharmaceuticals Inc
    0SEC
    895 shares0Common StockSEC:0000899866-14-000083:0
  • ●
    DirectorExecutivesSintx Technologies, Inc.
    0SEC
    57,864 sharesCommon StockSEC:0001209191-14-012944:0
  • ▼
    DirectorExecutivesAlexion Pharmaceuticals Inc
    2M USD0SEC
    12,426 shares@ US$154.02Common Stock, par value $.0001 per shareSEC:0000899866-14-000029:0
  • ▼
    DirectorExecutivesAlexion Pharmaceuticals Inc
    2M USD0SEC
    10,662 shares@ US$154.95Common Stock, par value $.0001 per shareSEC:0000899866-14-000029:1
  • ▼
    DirectorExecutivesAlexion Pharmaceuticals Inc
    2M USD0SEC
    13,912 shares@ US$155.91Common Stock, par value $.0001 per shareSEC:0000899866-14-000029:2
  • ▼
    DirectorExecutivesAlexion Pharmaceuticals Inc
    471,270 USD0SEC
    3,000 shares@ US$157.09Common Stock, par value $.0001 per shareSEC:0000899866-14-000029:3
  • ◆
    DirectorExecutivesAlexion Pharmaceuticals Inc
    0SEC
    2,471 shares0Common Stock, par value $.0001 per shareSEC:0000899866-13-000036:0
  • ▲
    DirectorExecutivesImunon, Inc.
    106,400 USD0SEC
    14,000 shares@ US$7.60Celsion Corporation Common StockSEC:0000749647-12-000045:0
    Canonical exit: 10 Mar 2013 (T+90)
  • ◇
    DirectorExecutivesImunon, Inc.
    55,520 USD0SEC
    17,083 shares@ US$3.25Celsion Corporation Common StockSEC:0000749647-12-000040:0
  • ◇
    DirectorExecutivesImunon, Inc.
    95,681 USD0SEC
    34,542 shares@ US$2.77Celsion Corporation Common StockSEC:0000749647-12-000040:1
  • ◇
    DirectorExecutivesImunon, Inc.
    79,062 USD0SEC
    18,735 shares@ US$4.22Celsion Corporation Common StockSEC:0000749647-12-000040:2
  • ◇
    DirectorExecutivesImunon, Inc.
    95,200 USD0SEC
    35,000 shares@ US$2.72Celsion Corporation Common StockSEC:0000749647-12-000039:0
  • ◇
    DirectorExecutivesAlexion Pharmaceuticals Inc
    433,600 USD0SEC
    40,000 shares@ US$10.84Common stock, par value $.0001 per shareSEC:0001231977-12-000070:0
  • ◇
    DirectorExecutivesAlexion Pharmaceuticals Inc
    720,400 USD0SEC
    40,000 shares@ US$18.01Common Stock, par value $.0001 per shareSEC:0001231977-12-000070:1
  • ▼
    DirectorExecutivesAlexion Pharmaceuticals Inc
    7M USD0SEC
    72,227 shares@ US$103.76Common Stock, par value $.0001 per shareSEC:0001231977-12-000068:0
  • ▼
    DirectorExecutivesAlexion Pharmaceuticals Inc
    3M USD0SEC
    27,446 shares@ US$104.24Common Stock, par value $.0001 per shareSEC:0001231977-12-000068:1
  • ▲
    DirectorExecutivesCytrx Corp
    21,276 USD0SEC
    68,789 shares@ US$0.3093Common StockSEC:0001250853-12-000028:0
    Canonical exit: 22 May 2012 (T+90)
  • ▲
    DirectorExecutivesCytrx Corp
    44,580 USD0SEC
    136,540 shares@ US$0.3265Common StockSEC:0001250853-12-000028:1
    Canonical exit: 23 May 2012 (T+90)
  • ◇
    DirectorExecutivesAlexion Pharmaceuticals Inc
    0SEC
    3,115 shares0Common Stock, par value $.0001 per shareSEC:0001231977-12-000012:0
  • ●
    DirectorExecutivesImunon, Inc.
    40,999 USD0SEC
    17,083 shares@ US$2.40Celsion Corporation Common StockSEC:0000749647-11-000114:0
  • ▲
    DirectorExecutivesImunon, Inc.
    199,998 USD0SEC
    46,838 shares@ US$4.27Celsion Corporation Common StockSEC:0000749647-11-000107:0
    Canonical exit: 23 Oct 2011 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    95,681 USD0SEC
    34,542 shares@ US$2.77Celsion Corporation Common StockSEC:0000749647-11-000064:0
    Canonical exit: 24 Aug 2011 (T+90)
  • ▼
    DirectorExecutivesAlexion Pharmaceuticals Inc
    5M USD0SEC
    47,637 shares@ US$95.00Common Stock, par value $.0001 per shareSEC:0001231977-11-000039:0
  • ●
    DirectorExecutivesAlexion Pharmaceuticals Inc
    0SEC
    00Common Stock, par value $.0001 per shareSEC:0001231977-11-000038:0

25 of 68 declarations